글루코트랙(GCTK)는 NASDAQ에 상장된 Healthcare · Medical Instruments & Supplies 기업입니다. 현재가 $0.37 (+0.52%), 시가총액 $0.00B, PER 0.07, 52주 범위 $0.10 ~ $10.59.
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
글루코트랙의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.
글루코트랙의 현재 주가는 $0.37 (+0.52%)입니다. BlackQuant에서 실시간 시세와 차트를 확인할 수 있습니다.
글루코트랙의 시가총액은 약 $0.00B입니다. PER은 0.07입니다.
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the